• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BCL11A在乳腺癌中的表达

BCL11A Expression in Breast Cancer.

作者信息

Kątnik Ewa, Gomułkiewicz Agnieszka, Piotrowska Aleksandra, Grzegrzółka Jędrzej, Rusak Agnieszka, Kmiecik Alicja, Ratajczak-Wielgomas Katarzyna, Dzięgiel Piotr

机构信息

Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland.

出版信息

Curr Issues Mol Biol. 2023 Mar 23;45(4):2681-2698. doi: 10.3390/cimb45040175.

DOI:10.3390/cimb45040175
PMID:37185699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10137054/
Abstract

B-cell leukemia/lymphoma 11A (BCL11A) is a transcription factor that regulates the expression of genes involved in cell division or apoptosis. A link between high BCL11A expression and a worse prognosis has been demonstrated in patients with various cancers. The aim of this study was to investigate the expression pattern of BCL11A in breast cancer (BC) cases and mastopathy samples and to correlate the results with the clinicopathological data. The expression of the BCL11A protein was investigated using immunohistochemistry (IHC) on 200 cases of BC and 13 mastopathy samples. The level of BCL11A mRNA was determined using real-time PCR in 22 cases of BC and 6 mastopathy samples. The expression of BCL11A was also examined at the protein and mRNA levels in BC cell lines. A higher expression level of BCL11A in BC cases was shown compared to mastopathy samples. The expression level of BCL11A in BC cases and in the studied cell lines decreased with the increasing grade of histological malignancy (G). It was also negatively correlated with the primary tumor size. A significantly lower expression of BCL11A was found in BC that did not express estrogen or progesterone receptors and in triple-negative cases. The results of our research suggest that BCL11A may be relevant in the development of BC.

摘要

B细胞白血病/淋巴瘤11A(BCL11A)是一种转录因子,可调节参与细胞分裂或细胞凋亡的基因的表达。在各种癌症患者中,已证实BCL11A高表达与较差的预后之间存在关联。本研究的目的是调查BCL11A在乳腺癌(BC)病例和乳腺病样本中的表达模式,并将结果与临床病理数据相关联。使用免疫组织化学(IHC)对200例BC病例和13例乳腺病样本进行BCL11A蛋白表达的研究。使用实时PCR在22例BC病例和6例乳腺病样本中测定BCL11A mRNA水平。还在BC细胞系中在蛋白质和mRNA水平上检测BCL11A的表达。与乳腺病样本相比,BC病例中BCL11A的表达水平更高。BC病例和所研究细胞系中BCL11A的表达水平随着组织学恶性程度(G)的增加而降低。它也与原发肿瘤大小呈负相关。在不表达雌激素或孕激素受体的BC以及三阴性病例中发现BCL11A的表达明显较低。我们的研究结果表明,BCL11A可能与BC的发生发展相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f9/10137054/6c300f3b21b6/cimb-45-00175-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f9/10137054/c8a7c0d92d89/cimb-45-00175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f9/10137054/22728441584c/cimb-45-00175-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f9/10137054/b09eaeeeab88/cimb-45-00175-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f9/10137054/a168e1af7343/cimb-45-00175-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f9/10137054/6c300f3b21b6/cimb-45-00175-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f9/10137054/c8a7c0d92d89/cimb-45-00175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f9/10137054/22728441584c/cimb-45-00175-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f9/10137054/b09eaeeeab88/cimb-45-00175-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f9/10137054/a168e1af7343/cimb-45-00175-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f9/10137054/6c300f3b21b6/cimb-45-00175-g005.jpg

相似文献

1
BCL11A Expression in Breast Cancer.BCL11A在乳腺癌中的表达
Curr Issues Mol Biol. 2023 Mar 23;45(4):2681-2698. doi: 10.3390/cimb45040175.
2
BCL11A Expression in Non-Small Cell Lung Cancers.BCL11A 在非小细胞肺癌中的表达。
Int J Mol Sci. 2023 Jun 7;24(12):9848. doi: 10.3390/ijms24129848.
3
MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.微小RNA-137通过干扰BCL11A与DNA甲基转移酶1的相互作用抑制三阴性乳腺癌的干性和肿瘤发生。
Cell Physiol Biochem. 2018;47(5):2147-2158. doi: 10.1159/000491526. Epub 2018 Jul 5.
4
BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer.BCL11A赋予雄激素受体阳性三阴性乳腺癌细胞侵袭和迁移能力。
Oncol Lett. 2020 Apr;19(4):2916-2924. doi: 10.3892/ol.2020.11383. Epub 2020 Feb 10.
5
[Knock-down of BCL11A expression in breast cancer cells promotes MDA-MB-231 cell apoptosis].[敲低乳腺癌细胞中BCL11A的表达可促进MDA-MB-231细胞凋亡]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Nov;32(11):1532-1535.
6
Clinical significance of BCL11A expression in ER-negative and PR-negative endometrial carcinoma.BCL11A在雌激素受体阴性和孕激素受体阴性子宫内膜癌中的表达的临床意义
Int J Clin Exp Pathol. 2018 Jun 1;11(6):3068-3075. eCollection 2018.
7
Downregulation of BCL11A by siRNA induces apoptosis in B lymphoma cell lines.通过小干扰RNA(siRNA)下调BCL11A可诱导B淋巴瘤细胞系凋亡。
Biomed Rep. 2013 Jan;1(1):47-52. doi: 10.3892/br.2012.9. Epub 2012 Sep 5.
8
BCL11A Is Oncogenic and Predicts Poor Outcomes in Natural Killer/T-Cell Lymphoma.BCL11A具有致癌性,并预示自然杀伤/T细胞淋巴瘤的预后不良。
Front Pharmacol. 2020 Jun 4;11:820. doi: 10.3389/fphar.2020.00820. eCollection 2020.
9
miR‑574‑5p attenuates proliferation, migration and EMT in triple‑negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL/TAZ/CTGF axis.miR-574-5p 通过靶向 BCL11A 和 SOX2 抑制 SKIL/TAZ/CTGF 轴来抑制三阴性乳腺癌细胞的增殖、迁移和 EMT。
Int J Oncol. 2020 May;56(5):1240-1251. doi: 10.3892/ijo.2020.4995. Epub 2020 Feb 20.
10
Expression and clinical implications of basic leucine zipper ATF-like transcription factor 2 in breast cancer.乳腺癌中碱性亮氨酸拉链 ATF 样转录因子 2 的表达及其临床意义。
BMC Cancer. 2021 Sep 26;21(1):1062. doi: 10.1186/s12885-021-08785-6.

引用本文的文献

1
Solution structure of the Z0 domain from transcription repressor BCL11A sheds light on the sequence properties of protein-binding zinc fingers.转录抑制因子BCL11A的Z0结构域的溶液结构揭示了蛋白质结合锌指的序列特性。
Protein Sci. 2025 Apr;34(4):e70097. doi: 10.1002/pro.70097.
2
Identification of BCL11A, NTN5, and OGN as Diagnosis Biomarker of Papillary Renal Cell Carcinomas by Bioinformatic Analysis.通过生物信息学分析鉴定BCL11A、NTN5和OGN作为乳头状肾细胞癌的诊断生物标志物
J Kidney Cancer VHL. 2025 Feb 28;12(1):12-22. doi: 10.15586/jkc.v12i1.366. eCollection 2025.
3
CD8 + T-Cell-Related Genes: Deciphering Their Role in the Pancreatic Adenocarcinoma TME and Their Effect on Prognosis.

本文引用的文献

1
Deciphering clinical significance of BCL11A isoforms and protein expression roles in triple-negative breast cancer subtype.解析 BCL11A 异构体在三阴性乳腺癌亚型中的临床意义和蛋白表达作用。
J Cancer Res Clin Oncol. 2023 Jul;149(7):3951-3963. doi: 10.1007/s00432-022-04301-w. Epub 2022 Aug 28.
2
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation.专为医学研究量身定制的基于网络的生存分析工具(KMplot):开发与应用
J Med Internet Res. 2021 Jul 26;23(7):e27633. doi: 10.2196/27633.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CD8 + T细胞相关基因:解读它们在胰腺腺癌肿瘤微环境中的作用及其对预后的影响
Dig Dis Sci. 2025 Jan;70(1):262-284. doi: 10.1007/s10620-024-08715-z. Epub 2024 Nov 27.
4
New insights into the role of the CHI3L2 protein in invasive ductal breast carcinoma.深入了解 CHI3L2 蛋白在乳腺浸润性导管癌中的作用。
Sci Rep. 2024 Nov 18;14(1):28529. doi: 10.1038/s41598-024-77930-5.
5
BCL11A Expression in Non-Small Cell Lung Cancers.BCL11A 在非小细胞肺癌中的表达。
Int J Mol Sci. 2023 Jun 7;24(12):9848. doi: 10.3390/ijms24129848.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer.乳腺癌中缺氧相关预后标志物及竞争性内源性RNA共表达网络
Front Oncol. 2020 Dec 2;10:579868. doi: 10.3389/fonc.2020.579868. eCollection 2020.
5
miR‑574‑5p attenuates proliferation, migration and EMT in triple‑negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL/TAZ/CTGF axis.miR-574-5p 通过靶向 BCL11A 和 SOX2 抑制 SKIL/TAZ/CTGF 轴来抑制三阴性乳腺癌细胞的增殖、迁移和 EMT。
Int J Oncol. 2020 May;56(5):1240-1251. doi: 10.3892/ijo.2020.4995. Epub 2020 Feb 20.
6
BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer.BCL11A通过激活乳腺癌中的Wnt/β-连环蛋白信号增强干性并促进进展。
Cancer Manag Res. 2019 Apr 11;11:2997-3007. doi: 10.2147/CMAR.S199368. eCollection 2019.
7
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
8
Combined diagnosis of breast cancer in the early stage by MRI and detection of gene expression.通过磁共振成像(MRI)和基因表达检测对早期乳腺癌进行联合诊断
Exp Ther Med. 2018 Aug;16(2):467-472. doi: 10.3892/etm.2018.6242. Epub 2018 May 31.
9
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression.环状 RNA EPSTI1 作为三阴性乳腺癌进展的预后标志物和介质。
Theranostics. 2018 Jul 1;8(14):4003-4015. doi: 10.7150/thno.24106. eCollection 2018.
10
MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.微小RNA-137通过干扰BCL11A与DNA甲基转移酶1的相互作用抑制三阴性乳腺癌的干性和肿瘤发生。
Cell Physiol Biochem. 2018;47(5):2147-2158. doi: 10.1159/000491526. Epub 2018 Jul 5.